Disulfiram and Naltrexone Interaction

Drug interaction information between Disulfiram and Naltrexone.

Disulfiram and Naltrexone have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Disulfiram and Naltrexone. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Disulfiram

Aldehyde Dehydrogenase Inhibitor

Drug B

Naltrexone

Opioid Antagonist

How They Interact

Both of these medications can be hard on the liver. Using them at the same time may increase your risk of developing liver problems.

FDA Label Information

The safety and efficacy of concomitant use of naltrexone hydrochloride and disulfiram is unknown, and the concomitant use of two potentially hepatotoxic medications is not ordinarily recommended unless the probable benefits outweigh the known risks.

Frequently Asked Questions

What SPL severity band is on file for Disulfiram + Naltrexone?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Disulfiram has 8 labeled pairs on file vs Naltrexone's 5. In the minor band specifically: Disulfiram has 7 (also Acamprosate, Amitriptyline, Metronidazole, Nabilone); Naltrexone has 5 (also Thioridazine, Acamprosate, Glecaprevir/Pibrentasvir, Nabilone).

What mechanism field is on file for Disulfiram and Naltrexone?

Both of these medications can be hard on the liver. Using them at the same time may increase your risk of developing liver problems.

Disulfiram's labeled portfolio outnumbers Naltrexone

SPL source-record counts only. This page's band is minor · classes on file: Disulfiram (Aldehyde Dehydrogenase Inhibitor); Naltrexone (Opioid Antagonist).

Disulfiram

0 major · 1 moderate · 7 minor · 8 total

Naltrexone

0 major · 0 moderate · 5 minor · 5 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.